Scarica l'app Stockscreener
30.70
0.39%
0.12
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché BAX Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$30.58
Aprire:
$30.66
Volume 24 ore:
3.46M
Relative Volume:
0.79
Capitalizzazione di mercato:
$15.75B
Reddito:
$11.89B
Utile/perdita netta:
$-560.00M
Rapporto P/E:
-27.91
EPS:
-1.1
Flusso di cassa netto:
$191.00M
1 W Prestazione:
+1.42%
1M Prestazione:
-0.90%
6M Prestazione:
-8.93%
1 anno Prestazione:
-7.50%
Intervallo 1D:
$30.10
$30.79
Intervallo di 1 settimana:
$29.72
$31.04
Portata 52W:
$26.25
$40.49
Baxter International Inc Stock (BAX) Company Profile
Nome
Baxter International Inc
Settore
Industria
Telefono
(224) 948-2000
Indirizzo
ONE BAXTER PARKWAY, DEERFIELD, IL
Confronta BAX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
BAX
Baxter International Inc
|
30.70 | 15.53B | 11.89B | -560.00M | 191.00M | -1.10 |
|
ISRG
Intuitive Surgical Inc
|
555.75 | 194.50B | 8.71B | 2.48B | 1.75B | 6.82 |
|
BDX
Becton Dickinson Co
|
173.82 | 49.39B | 20.87B | 1.50B | 2.59B | 5.24 |
|
ALC
Alcon Inc
|
86.35 | 42.61B | 9.93B | 1.12B | 1.58B | 2.25 |
|
RMD
Resmed Inc
|
245.12 | 36.00B | 5.02B | 1.31B | 1.56B | 8.91 |
|
COO
The Cooper Companies, Inc.
|
79.96 | 15.86B | 3.93B | 415.40M | 384.70M | 2.06 |
Baxter International Inc Stock (BAX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-02-26 | Ripresa | Goldman | Buy |
| 2025-02-24 | Aggiornamento | Argus | Hold → Buy |
| 2025-02-20 | Ripresa | Barclays | Overweight |
| 2024-07-15 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| 2024-05-30 | Iniziato | Goldman | Neutral |
| 2024-05-10 | Downgrade | TD Cowen | Buy → Hold |
| 2023-05-30 | Ripresa | Morgan Stanley | Equal-Weight |
| 2023-03-29 | Iniziato | UBS | Neutral |
| 2023-01-06 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2023-01-05 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2023-01-03 | Downgrade | BofA Securities | Buy → Neutral |
| 2022-12-19 | Downgrade | JP Morgan | Overweight → Neutral |
| 2022-12-15 | Downgrade | Deutsche Bank | Buy → Hold |
| 2022-12-12 | Downgrade | Citigroup | Buy → Neutral |
| 2022-10-18 | Iniziato | Barclays | Overweight |
| 2022-10-12 | Iniziato | Jefferies | Hold |
| 2022-06-24 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2022-04-04 | Downgrade | Goldman | Neutral → Sell |
| 2022-03-02 | Ripresa | BofA Securities | Buy |
| 2022-02-18 | Reiterato | KeyBanc Capital Markets | Overweight |
| 2022-02-18 | Reiterato | Morgan Stanley | Overweight |
| 2022-02-18 | Reiterato | Raymond James | Outperform |
| 2022-02-18 | Reiterato | Stifel | Buy |
| 2022-02-18 | Reiterato | UBS | Neutral |
| 2022-02-18 | Reiterato | Wells Fargo | Overweight |
| 2022-02-11 | Iniziato | Goldman | Neutral |
| 2022-01-07 | Ripresa | Citigroup | Buy |
| 2022-01-07 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2021-09-13 | Aggiornamento | Cowen | Market Perform → Outperform |
| 2021-09-03 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2021-05-25 | Iniziato | Barclays | Equal Weight |
| 2021-01-29 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2021-01-06 | Downgrade | UBS | Buy → Neutral |
| 2020-12-15 | Downgrade | Goldman | Buy → Neutral |
| 2020-10-01 | Aggiornamento | Citigroup | Neutral → Buy |
| 2020-09-04 | Downgrade | Argus | Buy → Hold |
| 2020-06-24 | Iniziato | Oppenheimer | Outperform |
| 2020-03-19 | Aggiornamento | Stifel | Hold → Buy |
| 2020-03-18 | Aggiornamento | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2020-03-05 | Iniziato | Citigroup | Neutral |
| 2020-02-13 | Iniziato | Goldman | Buy |
| 2020-01-02 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2019-12-17 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2019-06-26 | Iniziato | KeyBanc Capital Markets | Sector Weight |
| 2019-04-08 | Downgrade | Evercore ISI | Outperform → In-line |
| 2019-01-02 | Aggiornamento | Citigroup | Neutral → Buy |
| 2019-01-02 | Aggiornamento | Morgan Stanley | Underweight → Overweight |
| 2018-11-02 | Aggiornamento | Argus | Hold → Buy |
| 2018-10-16 | Iniziato | Barclays | Underweight |
| 2018-05-17 | Ripresa | Piper Jaffray | Overweight |
| 2018-02-06 | Reiterato | Citigroup | Neutral |
| 2018-01-03 | Iniziato | Evercore ISI | Outperform |
| 2018-01-03 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
Mostra tutto
Baxter International Inc Borsa (BAX) Ultime notizie
Vitiligo Market Forecast and Competitive Landscape Report 2025-2033 Featuring Incyte, Bristol-Myers Squibb, Clinuvel Pharmaceuticals, Astellas, Baxter, Pfizer, and Dr. Reddy's LaboratoriesResearchAndMarkets.com - FinancialContent
IV Bag Market Is Booming WorldwideBaxter, B. Braun - openPR.com
GF Fund Management CO. LTD. Acquires New Position in Baxter International Inc. (NYSE:BAX) - MarketBeat
BAXTER TO Present at Goldman Sachs 46th Annual Global Healthcare Conference 2025 | BAX Stock News - GuruFocus
BAXTER TO Present at Goldman Sachs 46th Annual Global Healthcare Conference 2025 - Business Wire
Q3 EPS Forecast for Baxter International Cut by Analyst - MarketBeat
Do These 3 Checks Before Buying Baxter International Inc. (NYSE:BAX) For Its Upcoming Dividend - simplywall.st
We Wouldn't Be Too Quick To Buy Baxter International Inc. (NYSE:BAX) Before It Goes Ex-Dividend - Yahoo Finance
Baxter International Inc. (NYSE:BAX) Given Consensus Rating of "Hold" by Analysts - MarketBeat
Raiffeisen Bank International AG Purchases Shares of 76,587 Baxter International Inc. (NYSE:BAX) - MarketBeat
Baxter launches room-temperature collagen sealing pad - MassDevice
Baxter launches HEMOPATCH Sealing Hemostat, a room-temperature collagen pad approved for Hemostasis and Sealing, suitable for open surgery and minimally invasive surgical procedures (MIS) - PR Newswire
Unpacking Q1 Earnings: Baxter (NYSE:BAX) In The Context Of Other Medical Devices & SuppliesDiversified Stocks - Yahoo Finance
Parkwood LLC Invests $10.75 Million in Baxter International Inc. (NYSE:BAX) - MarketBeat
Baxter International Inc. (NYSE:BAX) Receives Consensus Rating of “Hold” from Analysts - Defense World
Baxter’s Q4 Performance Beats Expectations - Medical Product Outsourcing
Baxter at Bank of America 2025 Healthcare Conference: Strategic Shifts and Growth - Investing.com Nigeria
Becton Dickinson Sues Baxter Over Infusion Pump Patents - Law360
BD files patent infringement lawsuit against Baxter over infusion pump tech - Drug Delivery Business
Becton Dickinson Says Baxter Infringes Infusion-Pump Patents - Bloomberg Law News
Transcript : Baxter International Inc. Presents at BofA Securities 2025 Healthcare Conference, May-13-2025 08 - marketscreener.com
Hurricane Helene Updates - Baxter
Ameriprise Financial Inc. Sells 2,346,164 Shares of Baxter International Inc. (NYSE:BAX) - MarketBeat
Morgan Stanley Has Lowered Expectations for Baxter International (NYSE:BAX) Stock Price - MarketBeat
Baxter International Inc. (BAX) Announces Results of 2025 Annual Meeting - GuruFocus
Baxter International Holds 2025 Annual Meeting with Key Decisions - TipRanks
Baxter International Inc (BAX) Shares Up 4.23% on May 8 - GuruFocus
The 'Goldilocks' Case For Baxter International (NYSE:BAX) - Seeking Alpha
SHAREHOLDER ALERT: Potential Recovery for Baxter International Inc. (BAX) Investors Affected by Stock DropLevi & Korsinsky Pursuing Class Action Lawsuit - ACCESS Newswire
Baxter International First Quarter 2025 Earnings: Beats Expectations - Yahoo Finance
Beyond the Balance Sheet: What SWOT Reveals About Baxter Interna - GuruFocus
Baxter International IncDeclares Quarterly Dividend Of $0.17 Per Share - marketscreener.com
Baxter Declares Quarterly Dividend | BAX Stock News - GuruFocus
Baxter Declares Quarterly Dividend - Bluefield Daily Telegraph
Hurricane Helene impact on Baxter to further limit IV fluid supply, HHS says - AOL.com
What Are Wall Street Analysts' Target Price For Baxter International Stock? - Barchart.com
What Are Wall Street Analysts' Target Price for Baxter International Stock? - inkl
Analysts Offer Insights on Healthcare Companies: Baxter International (BAX) and Vera Therapeutics (VERA) - The Globe and Mail
Wells Fargo & Company Issues Pessimistic Forecast for Baxter International (NYSE:BAX) Stock Price - Defense World
Baxter stock rises on earnings beat, guidance raise - MSN
Baxter International Inc. (NYSE:BAX) Q1 2025 Earnings Call Transcript - Insider Monkey
Health care company says Trump tariffs will cost it $60M–$70M this year - Ars Technica
Baxter International Inc. (NYSE:BAX) Shares Sold by Banco Bilbao Vizcaya Argentaria S.A. - MarketBeat
Baxter Intl (BAX): Wells Fargo Lowers Price Target to $33 | BAX Stock News - GuruFocus
Baxter (BAX) Target Price Reduced by Stifel Amid Strong Q1 Results | BAX Stock News - GuruFocus
Wells Fargo Adjusts Baxter International Price Target to $33 From $36 - marketscreener.com
Citigroup Adjusts Price Target on Baxter International to $34 From $35 - marketscreener.com
JPMorgan Adjusts Price Target on Baxter International to $34 From $36 - marketscreener.com
Here's Why Baxter International (NYSE:BAX) Has A Meaningful Debt Burden - simplywall.st
Baxter International Inc Azioni (BAX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.20%
1.63%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):